Helix is the leading population genomics and viral surveillance company. Helix enables health systems, public health organizations and life sciences companies to accelerate the integration of genomic data into patient care and public health decision making. Learn more at www.helix.com.

Achieve therapeutic targets and improve sample efficiency. InsightRX Nova standardizes precision dosing across your institution, improving efficacy, minimizing variability, and
reducing adverse events—all while lowering blood sampling by up to 50%.

Improve model accuracy and stay up to date. InsightRX Nova gives you access to the most up to date, clinically validated models developed by our partners and curated from the
literature. In addition, dosing guidance improves over time as we update models using our proprietary human-assisted AI framework and data from the InsightRX network.

Capture results and outcomes. InsightRX Nova includes reports on your institution’s target performance compared to national benchmarks or your institutional data. For more powerful analytics, InsightRX Apollo provides dashboards enabling you to understand how targets are being met across drugs, providers, and subpopulations.